Rapid Influenza Diagnostic Tests (RIDT) Market Size, Share, And Growth Report 2032

Rapid Influenza Diagnostic Tests (RIDT) Market: Size

The global Rapid Influenza Diagnostic Tests (RIDT) Market size was worth around USD 1060.14 million in 2023 and is predicted to grow to around USD 2049.62 million by 2032 with a compound annual growth rate (CAGR) of roughly 7.6% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD million). The report covers a forecast and an analysis of the Rapid Influenza Diagnostic Tests (RIDT) Market on a global and regional level.

Request Free Sample

Rapid Influenza Diagnostic Tests (RIDT) Market: Overview

Influenza is one of the major disease burdens worldwide and early detection is important for emerging pandemic strains. Influenza virus can be detected using virus isolation in cell culture, direct antigen detection or RT-PCR (reverse transcriptase-polymerase chain reaction) based detection of influenza specific RNA. Wide range of rapid detection test kits are available commercially. Rapid influenza diagnostic test (RIDT) detects presence of influenza viral nucleoprotein antigen for diagnosis of current influenza infection. Commercially used RIDTs can detect the infection within 30 minutes. These tests mostly use immunoassays to detect viral antigen. However some tests detect neuraminidase activity. Rapid detection tests help reduce blood tests and chest radiography in clinical settings.

The demand for rapid influenza diagnostic tests market is driven by growing demand for quick and cheaper diagnostic tests, increasing government initiatives to control influenza outbreaks, increasing geriatric population and technological advancements in immunoassay techniques and manufacturing of diagnostic kits. Additionally, increasing awareness, easy availability of test kits and increasing healthcare expenditure in developing countries are expected to propel the market growth. However, lack of skilled professionals may restrain the market growth.

Global Rapid Influenza Diagnostic Tests (RIDT) Market Size : Segmentation

The study provides a crucial view on the rapid influenza diagnostic tests by segmenting the market based on product, patient, end user and region. All the segments of rapid influenza diagnostic tests market have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on product, global rapid influenza diagnostic tests market is bifurcated into influenza B RIDT and influenza A RIDT. Influenza A RIDT accounted for largest market share in 2023 and is projected to hold its dominance over the forecast period. Growing number of population suffering from influenza worldwide will positively impact the RIDT for influenza A product market growth.

Based on patient market is segmented into adult and pediatric. Adult patient population segment accounted for the largest market share in 2023 and pediatric patient type segment is projected to grow rapidly over the forecast period. Increasing risk of influenza in pediatric patients will boost the market growth for pediatric segment.

The end user segment is divided into research laboratories, diagnostics centers, hospitals and other end users. Hospitals were the largest end users for rapid influenza diagnostic tests market in 2023. Large patient pool, presence of developed infrastructure in hospitals attribute to the largest market share.

Rapid Influenza Diagnostic Tests (RIDT) Market: Report Scope

Global Rapid Influenza Diagnostic Tests (RIDT) Market Size : Regional Analysis

North America held largest market share of the global rapid influenza diagnostic tests market in 2023. Government initiatives to control influenza outbreaks, growing awareness, increasing healthcare spending and availability of technological advanced products are factors driving the market in this region. Europe was second dominating market. Asia Pacific region is estimated to be highly growing market for rapid influenza diagnostic tests. Growing awareness, increasing health care spending, increasing geriatric population base are factors driving the market growth. Latin America is expected to register moderate growth over the forecast period. Middle East and Africa will register slower growth compared to other regions due to poor infrastructure and poverty.

Global Rapid Influenza Diagnostic Tests (RIDT) Market Size: Competitive Players

• Becton
• Dickinson and Company
• DiaSorin S.p.A
• SA Scientific
• Meridian Bioscience Inc.
• CorisBioconcep
• Analytik Jena
• Abbott
• Quidel Corporation
• Roche
• Princeton BioMeditech Corporation
• Among Others

The Global Rapid Influenza Diagnostic Tests (RIDT) Market is segmented as follows:

Global Rapid Influenza Diagnostic Tests Market: Product

• Rapid Influenza Diagnostic Test for Influenza A
• Rapid Influenza Diagnostic Test for Influenza B

Global Rapid Influenza Diagnostic Tests Market: By Patient

• Pediatric
• Adult

Global Rapid Influenza Diagnostic Tests Market: By End User

• Hospitals
• Diagnostics Centers
• Research Laboratories
• Other End Users

Global Rapid Influenza Diagnostic Tests Market: By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa